Toh C H, Castillo M
From the Department of Medical Imaging and Intervention (C.H.T.), Chang Gung Memorial Hospital at Linkou and Chang Gung University College of Medicine, Tao-Yuan, Taiwan
Department of Radiology (M.C.), University of North Carolina School of Medicine, Chapel Hill, North Carolina.
AJNR Am J Neuroradiol. 2017 Feb;38(2):288-293. doi: 10.3174/ajnr.A5015. Epub 2016 Nov 17.
The serial imaging changes describing the growth of glioblastomas from small to large tumors are seldom reported. Our aim was to classify the imaging patterns of early-stage glioblastomas and to define the order of appearance of different imaging patterns that occur during the growth of small glioblastomas.
Medical records and preoperative MR imaging studies of patients diagnosed with glioblastoma between 2006 and 2013 were reviewed. Patients were included if their MR imaging studies showed early-stage glioblastomas, defined as small MR imaging lesions detected early in the course of the disease, demonstrating abnormal signal intensity but the absence of classic imaging findings of glioblastoma. Each lesion was reviewed by 2 neuroradiologists independently for location, signal intensity, involvement of GM and/or WM, and contrast-enhancement pattern on MR imaging.
Twenty-six patients with 31 preoperative MR imaging studies met the inclusion criteria. Early-stage glioblastomas were classified into 3 types and were all hyperintense on FLAIR/T2-weighted images. Type I lesions predominantly involved cortical GM ( = 3). Type II ( = 12) and III ( = 16) lesions involved both cortical GM and subcortical WM. Focal contrast enhancement was present only in type III lesions at the gray-white junction. Interobserver agreement was excellent (κ = 0.95; < .001) for lesion-type classification. Transformations of lesions from type I to type II and type II to type III were observed on follow-up MR imaging studies. The early-stage glioblastomas of 16 patients were pathologically confirmed after imaging progression to classic glioblastoma.
Cortical lesions may be the earliest MR imaging-detectable abnormality in some human glioblastomas. These cortical tumors may progress to involve WM.
描述胶质母细胞瘤从小肿瘤生长为大肿瘤的系列影像学变化鲜有报道。我们的目的是对早期胶质母细胞瘤的影像学模式进行分类,并确定小胶质母细胞瘤生长过程中不同影像学模式出现的顺序。
回顾了2006年至2013年间诊断为胶质母细胞瘤患者的病历和术前磁共振成像(MR)研究。如果患者的MR成像研究显示为早期胶质母细胞瘤则纳入研究,早期胶质母细胞瘤定义为在疾病过程中早期检测到的小MR成像病变,表现为异常信号强度,但无胶质母细胞瘤的典型影像学表现。由2名神经放射科医生独立对每个病变的位置、信号强度、对灰质和/或白质的累及情况以及MR成像上的对比增强模式进行评估。
26例患者的31项术前MR成像研究符合纳入标准。早期胶质母细胞瘤分为3型,在液体衰减反转恢复序列/ T2加权图像上均为高信号。I型病变主要累及皮质灰质(n = 3)。II型(n = 12)和III型(n = 16)病变累及皮质灰质和皮质下白质。仅III型病变在灰白质交界处有局灶性对比增强。观察者间对病变类型分类的一致性极佳(κ = 0.95;P <.001)。在随访MR成像研究中观察到病变从I型向II型以及从II型向III型的转变。16例患者的早期胶质母细胞瘤在影像学进展为典型胶质母细胞瘤后经病理证实。
皮质病变可能是某些人类胶质母细胞瘤最早可通过MR成像检测到的异常。这些皮质肿瘤可能进展累及白质。